Last reviewed · How we verify

Sabin IPV + Sabin IPV + Sabin IPV

Zhejiang Provincial Center for Disease Control and Prevention · FDA-approved active Biologic

Sabin IPV + Sabin IPV + Sabin IPV is a inactivated viral vaccine Biologic drug developed by Zhejiang Provincial Center for Disease Control and Prevention. It is currently FDA-approved for Prevention of poliomyelitis caused by poliovirus types 1, 2, and 3.

Sabin IPV is an inactivated polio vaccine that stimulates the immune system to produce antibodies against all three poliovirus serotypes (1, 2, and 3).

Sabin IPV is an inactivated polio vaccine that stimulates the immune system to produce antibodies against all three poliovirus serotypes (1, 2, and 3). Used for Prevention of poliomyelitis caused by poliovirus types 1, 2, and 3.

At a glance

Generic nameSabin IPV + Sabin IPV + Sabin IPV
SponsorZhejiang Provincial Center for Disease Control and Prevention
Drug classinactivated viral vaccine
Targetpoliovirus serotypes 1, 2, and 3
ModalityBiologic
Therapeutic areaImmunology / Infectious Disease
PhaseFDA-approved

Mechanism of action

Sabin IPV contains inactivated (killed) poliovirus particles that trigger humoral and cellular immune responses without causing disease. The vaccine elicits production of neutralizing antibodies against poliovirus types 1, 2, and 3, providing protection against poliomyelitis. The triple formulation ensures comprehensive coverage against all circulating wild-type and vaccine-derived poliovirus strains.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Sabin IPV + Sabin IPV + Sabin IPV

What is Sabin IPV + Sabin IPV + Sabin IPV?

Sabin IPV + Sabin IPV + Sabin IPV is a inactivated viral vaccine drug developed by Zhejiang Provincial Center for Disease Control and Prevention, indicated for Prevention of poliomyelitis caused by poliovirus types 1, 2, and 3.

How does Sabin IPV + Sabin IPV + Sabin IPV work?

Sabin IPV is an inactivated polio vaccine that stimulates the immune system to produce antibodies against all three poliovirus serotypes (1, 2, and 3).

What is Sabin IPV + Sabin IPV + Sabin IPV used for?

Sabin IPV + Sabin IPV + Sabin IPV is indicated for Prevention of poliomyelitis caused by poliovirus types 1, 2, and 3.

Who makes Sabin IPV + Sabin IPV + Sabin IPV?

Sabin IPV + Sabin IPV + Sabin IPV is developed and marketed by Zhejiang Provincial Center for Disease Control and Prevention (see full Zhejiang Provincial Center for Disease Control and Prevention pipeline at /company/zhejiang-provincial-center-for-disease-control-and-prevention).

What drug class is Sabin IPV + Sabin IPV + Sabin IPV in?

Sabin IPV + Sabin IPV + Sabin IPV belongs to the inactivated viral vaccine class. See all inactivated viral vaccine drugs at /class/inactivated-viral-vaccine.

What development phase is Sabin IPV + Sabin IPV + Sabin IPV in?

Sabin IPV + Sabin IPV + Sabin IPV is FDA-approved (marketed).

What are the side effects of Sabin IPV + Sabin IPV + Sabin IPV?

Common side effects of Sabin IPV + Sabin IPV + Sabin IPV include Injection site pain, redness, or swelling, Fever, Myalgia.

What does Sabin IPV + Sabin IPV + Sabin IPV target?

Sabin IPV + Sabin IPV + Sabin IPV targets poliovirus serotypes 1, 2, and 3 and is a inactivated viral vaccine.

Related